Amicus Therapeutics Ownership 2024 | Who Owns Amicus Therapeutics Now?
Institutional Ownership
107.44%
Insider Ownership
0.75%
Retail Ownership
-8.19%
Institutional Holders
257.00
Amicus Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 9.56% | 0.01% | 28,204,309 | -288,177 | -1.01% | 332,246,759 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 9.51% | 5.74% | 28,057,456 | - | - | 330,516,832 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 9.28% | 3.76% | 27,400,000 | - | - | 322,772,000 | Mar 31, 2024 |
| BLACKROCK INC. | 7.74% | 0.01% | 22,849,449 | -138,690 | -0.60% | 269,166,511 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.37% | 0.04% | 18,803,645 | 3,613,621 | 23.79% | 221,506,938 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 5.32% | 0.02% | 15,691,157 | -2,157,374 | -12.09% | 184,841,838 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 4.68% | 0.09% | 13,814,514 | 2,307,385 | 20.05% | 162,712,883 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 4.49% | 5.73% | 13,257,286 | -1,571,035 | -10.59% | 156,170,829 | Mar 31, 2024 |
| STATE STREET CORP | 4.22% | 0.01% | 12,442,501 | -720,584 | -5.47% | 146,572,662 | Mar 31, 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.90% | 0.35% | 11,526,279 | -120,747 | -1.04% | 135,779,567 | Mar 31, 2024 |
| MORGAN STANLEY | 3.29% | 0.01% | 9,704,848 | -3,623,049 | -27.18% | 114,323,110 | Mar 31, 2024 |
| PALO ALTO INVESTORS LP | 3.17% | 12.41% | 9,344,102 | -1,029,613 | -9.93% | 110,073,522 | Mar 31, 2024 |
| MACQUARIE GROUP LTD | 2.40% | 0.09% | 7,070,733 | -144,277 | -2.00% | 83,293,000 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.29% | 0.09% | 6,767,373 | -227,224 | -3.25% | 79,865,954 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.10% | 0.01% | 6,210,736 | 259,441 | 4.36% | 73,172,564 | Mar 31, 2024 |
| FIERA CAPITAL CORP | 1.77% | 0.18% | 5,222,329 | 160,685 | 3.17% | 61,519,036 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.63% | 0.04% | 4,800,899 | 218,832 | 4.78% | 56,554,590 | Mar 31, 2024 |
| DEUTSCHE BANK AG\ | 1.47% | 0.02% | 4,351,081 | -1,427,663 | -24.71% | 51,255,734 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 1.07% | 0.01% | 3,156,082 | 311,331 | 10.94% | 37,178,645 | Mar 31, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.89% | 0.01% | 2,641,537 | 226,447 | 9.38% | 31,117,306 | Mar 31, 2024 |
Amicus Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 9.56% of the company's total share outstanding, currently valued at $332.25M. The top 10 institutional shareholders own together 65.06% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PALO ALTO INVESTORS LP | 3.17% | 12.41% | 9,344,102 | -1,029,613 | -9.93% | 110,073,522 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 9.51% | 5.74% | 28,057,456 | - | - | 330,516,832 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 4.49% | 5.73% | 13,257,286 | -1,571,035 | -10.59% | 156,170,829 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.52% | 4.82% | 1,547,141 | 684,326 | 79.31% | 18,225,321 | Mar 31, 2024 |
| CM MANAGEMENT, LLC | 0.15% | 4.45% | 450,000 | - | - | 5,301,000 | Mar 31, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.30% | 4.24% | 898,381 | 698,408 | 349.25% | 10,582,928 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 9.28% | 3.76% | 27,400,000 | - | - | 322,772,000 | Mar 31, 2024 |
| GREAT POINT PARTNERS LLC | 0.51% | 2.75% | 1,495,500 | 215,000 | 16.79% | 17,616,990 | Mar 31, 2024 |
| NOVO HOLDINGS A/S | 0.85% | 2.03% | 2,500,000 | - | - | 29,450,000 | Mar 31, 2024 |
| HEALTHINVEST PARTNERS AB | 0.09% | 1.81% | 252,307 | 203,597 | 417.98% | 2,972,176 | Mar 31, 2024 |
| BIOIMPACT CAPITAL LLC | 0.24% | 1.36% | 718,970 | 3,087 | 0.43% | 8,469,467 | Mar 31, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.06% | 1.24% | 175,000 | 35,000 | 25.00% | 2,061,500 | Mar 31, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.07% | 1.02% | 221,044 | 64,275 | 41.00% | 2,603,898 | Mar 31, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.35% | 0.69% | 1,028,569 | -37,396 | -3.51% | 12,116,543 | Mar 31, 2024 |
| AMBASSADOR ADVISORS, LLC | 0.09% | 0.58% | 273,508 | 2,515 | 0.93% | 3,221,924 | Mar 31, 2024 |
| GRANITE INVESTMENT PARTNERS, LLC | 0.31% | 0.41% | 918,834 | 918,834 | 100.00% | 10,823,865 | Mar 31, 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.90% | 0.35% | 11,526,279 | -120,747 | -1.04% | 135,779,567 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.39% | 0.34% | 1,152,656 | 88,850 | 8.35% | 13,578,288 | Mar 31, 2024 |
| OSTERWEIS CAPITAL MANAGEMENT INC | 0.16% | 0.33% | 484,060 | 484,060 | 100.00% | 5,702,227 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.08% | 0.33% | 226,723 | 226,723 | 100.00% | 2,670,797 | Mar 31, 2024 |
The largest Amicus Therapeutics shareholder by % of total assets is PALO ALTO INVESTORS LP. The company owns 9.34M shares of Amicus Therapeutics (FOLD), representing 12.41% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 6.37% | 0.04% | 18,803,645 | 3,613,621 | 23.79% | 221,506,938 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 4.68% | 0.09% | 13,814,514 | 2,307,385 | 20.05% | 162,712,883 | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.74% | 0.09% | 2,176,600 | 1,858,100 | 583.39% | 25,640,348 | Mar 31, 2024 |
| ABRDN PLC | 0.55% | 0.04% | 1,622,399 | 1,622,399 | 100.00% | 19,111,861 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.46% | 0.00% | 1,351,182 | 1,308,411 | 3059.11% | 15,916,924 | Mar 31, 2024 |
| GRANITE INVESTMENT PARTNERS, LLC | 0.31% | 0.41% | 918,834 | 918,834 | 100.00% | 10,823,865 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.32% | 0.02% | 956,200 | 878,800 | 1135.40% | 11,264,000 | Mar 31, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.30% | 4.24% | 898,381 | 698,408 | 349.25% | 10,582,928 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.52% | 4.82% | 1,547,141 | 684,326 | 79.31% | 18,225,321 | Mar 31, 2024 |
| 0.23% | 0.03% | 665,723 | 665,723 | 100.00% | 7,988,676 | Mar 31, 2024 | |
| INVESCO LTD. | 0.26% | 0.00% | 765,888 | 600,212 | 362.28% | 9,022,162 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.44% | 0.06% | 1,313,170 | 578,303 | 78.69% | 15,469,143 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.19% | 0.01% | 556,363 | 556,363 | 100.00% | 6,553,956 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.21% | 0.04% | 613,391 | 520,118 | 557.63% | 7,225,746 | Mar 31, 2024 |
| OSTERWEIS CAPITAL MANAGEMENT INC | 0.16% | 0.33% | 484,060 | 484,060 | 100.00% | 5,702,227 | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.27% | 0.05% | 802,500 | 442,500 | 122.92% | 9,453,450 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.14% | 0.03% | 400,000 | 400,000 | 100.00% | 120,000 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 1.07% | 0.01% | 3,156,082 | 311,331 | 10.94% | 37,178,645 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.22% | 0.06% | 643,385 | 271,005 | 72.78% | 7,579,000 | Mar 31, 2024 |
| CITIGROUP INC | 0.25% | 0.01% | 733,136 | 261,818 | 55.55% | 8,636,341 | Mar 31, 2024 |
As of Mar 31 2024, Amicus Therapeutics's largest institutional buyer is WELLINGTON MANAGEMENT GROUP LLP. The company purchased 3.61M stocks of FOLD, valued at $221.51M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 3.29% | 0.01% | 9,704,848 | -3,623,049 | -27.18% | 114,323,110 | Mar 31, 2024 |
| ARTAL GROUP S.A. | - | - | - | -2,500,000 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 5.32% | 0.02% | 15,691,157 | -2,157,374 | -12.09% | 184,841,838 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 4.49% | 5.73% | 13,257,286 | -1,571,035 | -10.59% | 156,170,829 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -1,556,540 | -100.00% | - | Mar 31, 2024 |
| FINEPOINT CAPITAL LP | - | - | - | -1,489,025 | -100.00% | - | Mar 31, 2024 |
| DEUTSCHE BANK AG\ | 1.47% | 0.02% | 4,351,081 | -1,427,663 | -24.71% | 51,255,734 | Mar 31, 2024 |
| PALO ALTO INVESTORS LP | 3.17% | 12.41% | 9,344,102 | -1,029,613 | -9.93% | 110,073,522 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 0.34% | 0.30% | 1,011,776 | -1,014,588 | -50.07% | 11,918,721 | Mar 31, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -947,418 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.45% | 0.00% | 1,341,890 | -780,855 | -36.79% | 15,807,464 | Mar 31, 2024 |
| STATE STREET CORP | 4.22% | 0.01% | 12,442,501 | -720,584 | -5.47% | 146,572,662 | Mar 31, 2024 |
| FMR LLC | 0.59% | 0.00% | 1,747,546 | -446,914 | -20.37% | 20,586,092 | Mar 31, 2024 |
| BARCLAYS PLC | 0.12% | 0.00% | 348,937 | -378,838 | -52.05% | 4,110,000 | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.20% | 0.01% | 588,635 | -334,410 | -36.23% | 6,934,120 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -299,500 | -100.00% | - | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -295,500 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | 9.56% | 0.01% | 28,204,309 | -288,177 | -1.01% | 332,246,759 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.39% | 0.00% | 1,147,544 | -255,028 | -18.18% | 13,518,068 | Mar 31, 2024 |
| NEUBERGER BERMAN GROUP LLC | 0.16% | 0.00% | 468,652 | -249,062 | -34.70% | 5,520,720 | Mar 31, 2024 |
As of Mar 31 2024, Amicus Therapeutics's biggest institutional seller is MORGAN STANLEY. The company sold -3.62M shares of FOLD, valued at $114.32M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ABRDN PLC | 0.55% | 0.04% | 1,622,399 | 1,622,399 | 100.00% | 19,111,861 | Mar 31, 2024 |
| GRANITE INVESTMENT PARTNERS, LLC | 0.31% | 0.41% | 918,834 | 918,834 | 100.00% | 10,823,865 | Mar 31, 2024 |
| 0.23% | 0.03% | 665,723 | 665,723 | 100.00% | 7,988,676 | Mar 31, 2024 | |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.19% | 0.01% | 556,363 | 556,363 | 100.00% | 6,553,956 | Mar 31, 2024 |
| OSTERWEIS CAPITAL MANAGEMENT INC | 0.16% | 0.33% | 484,060 | 484,060 | 100.00% | 5,702,227 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.14% | 0.03% | 400,000 | 400,000 | 100.00% | 120,000 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.08% | 0.33% | 226,723 | 226,723 | 100.00% | 2,670,797 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 0.00% | 144,500 | 144,500 | 100.00% | 1,702,210 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.03% | 0.00% | 101,899 | 101,899 | 100.00% | 1,200,370 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.03% | 0.00% | 101,623 | 101,623 | 100.00% | 1,197,119 | Mar 31, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 84,800 | 84,800 | 100.00% | 999,000 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.03% | 0.01% | 77,976 | 77,976 | 100.00% | 918,556 | Mar 31, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.02% | 0.00% | 69,431 | 69,431 | 100.00% | 817,897 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.02% | 0.00% | 64,300 | 64,300 | 100.00% | 757,454 | Mar 31, 2024 |
| EISLER CAPITAL (US) LLC | 0.02% | 0.02% | 60,383 | 60,383 | 100.00% | 711,312 | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.02% | 0.05% | 57,966 | 57,966 | 100.00% | 682,839 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.02% | 0.06% | 50,200 | 50,200 | 100.00% | 591,356 | Mar 31, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.11% | 46,802 | 46,802 | 100.00% | 551,328 | Mar 31, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.01% | 0.06% | 43,998 | 43,998 | 100.00% | 518,000 | Mar 31, 2024 |
| 0.01% | 0.02% | 43,178 | 43,178 | 100.00% | 508,637 | Mar 31, 2024 | |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 0.01% | 0.03% | 31,599 | 31,599 | 100.00% | 372,236 | Mar 31, 2024 |
| HSBC HOLDINGS PLC | 0.01% | 0.00% | 30,464 | 30,464 | 100.00% | 358,866 | Mar 31, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.09% | 29,469 | 29,469 | 100.00% | 347,145 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.01% | 0.00% | 24,576 | 24,576 | 100.00% | 289,505 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 18,767 | 18,767 | 100.00% | 221,075 | Mar 31, 2024 |
| CAPULA MANAGEMENT LTD | 0.01% | 0.00% | 17,000 | 17,000 | 100.00% | 200,260 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.01% | 0.00% | 16,489 | 16,489 | 100.00% | 194,240 | Mar 31, 2024 |
| CERITY PARTNERS LLC | 0.01% | 0.00% | 16,158 | 16,158 | 100.00% | 190,339 | Mar 31, 2024 |
| TRUIST FINANCIAL CORP | 0.00% | 0.00% | 14,296 | 14,296 | 100.00% | 168,407 | Mar 31, 2024 |
| MML INVESTORS SERVICES, LLC | 0.00% | 0.00% | 10,520 | 10,520 | 100.00% | 124,000 | Mar 31, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.16% | 5,600 | 5,600 | 100.00% | 65,968,000 | Mar 31, 2024 |
| TORNO CAPITAL, LLC | 0.00% | 0.00% | 4,000 | 4,000 | 100.00% | 47,120 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | 0.00% | 3,468 | 3,468 | 100.00% | 40,853 | Mar 31, 2024 |
| STATE OF WYOMING | 0.00% | 0.01% | 3,193 | 3,193 | 100.00% | 37,614 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 2,700 | 2,700 | 100.00% | 31,806 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 1,959 | 1,959 | 100.00% | 23,018,000 | Mar 31, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 374 | 374 | 100.00% | 4,406 | Mar 31, 2024 |
| JFS WEALTH ADVISORS, LLC | 0.00% | 0.00% | 282 | 282 | 100.00% | 3,322 | Mar 31, 2024 |
| CONTINUUM ADVISORY, LLC | - | 0.00% | 141 | 141 | 100.00% | 1,337,000 | Mar 31, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | - | - | 65 | 65 | 100.00% | 766 | Mar 31, 2024 |
Amicus Therapeutics's largest new institutional shareholder by number of shares is ABRDN PLC, purchased 1.62M shares, valued at $19.11M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | - | - | - | -2,500,000 | -100.00% | - | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -1,556,540 | -100.00% | - | Mar 31, 2024 |
| FINEPOINT CAPITAL LP | - | - | - | -1,489,025 | -100.00% | - | Mar 31, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -947,418 | -100.00% | - | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -299,500 | -100.00% | - | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -295,500 | -100.00% | - | Mar 31, 2024 |
| ALGERT GLOBAL LLC | - | - | - | -184,540 | -100.00% | - | Mar 31, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -149,387 | -100.00% | - | Mar 31, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -143,700 | -100.00% | - | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -110,665 | -100.00% | - | Mar 31, 2024 |
| NATIXIS | - | - | - | -47,250 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -33,514 | -100.00% | - | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -19,000 | -100.00% | - | Mar 31, 2024 |
| GTS SECURITIES LLC | - | - | - | -17,100 | -100.00% | - | Mar 31, 2024 |
| CIPHER CAPITAL LP | - | - | - | -16,162 | -100.00% | - | Mar 31, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -14,400 | -100.00% | - | Mar 31, 2024 |
| OLD WELL PARTNERS, LLC | - | - | - | -12,700 | -100.00% | - | Mar 31, 2024 |
| BEIRNE WEALTH CONSULTING SERVICES, LLC | - | - | - | -10,933 | -100.00% | - | Mar 31, 2024 |
| CALTON & ASSOCIATES, INC. | - | - | - | -10,011 | -100.00% | - | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -8,700 | -100.00% | - | Mar 31, 2024 |
| RONALD BLUE TRUST, INC. | - | - | - | -240 | -100.00% | - | Mar 31, 2024 |
Amicus Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -2.50M shares, valued at -, as of undefined.
Amicus Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Fiera Capital Series Trust | 6.55% | 130,471 | -4,759 | -3.52% | Jun 30, 2023 |
| Manager Directed Portfolios | 4.81% | 787,369 | - | - | Jan 31, 2024 |
| SPARROW FUNDS | 4.31% | 15,365 | - | - | Feb 29, 2024 |
| Elevation Series Trust | 1.15% | 56,541 | 16,218 | 40.22% | Jan 31, 2024 |
| WANGER ADVISORS TRUST | 1.09% | 683,804 | - | - | Dec 31, 2023 |
| HARTFORD HLS SERIES FUND II INC | 1.07% | 262,287 | -267,195 | -50.46% | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.78% | 1,618,012 | - | - | Feb 29, 2024 |
| HIGHLAND FUNDS II | 0.53% | 7,817 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.42% | 4,275,849 | 2,069,738 | 93.82% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.41% | 201,243 | - | - | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.36% | 205,249 | - | - | Dec 31, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.34% | 382,028 | - | - | Dec 31, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.26% | 940,700 | - | - | Dec 31, 2023 |
| Voya EQUITY TRUST | 0.21% | 311,848 | 47,624 | 18.02% | Feb 29, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.18% | 10,154,896 | 4,034,575 | 65.92% | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.16% | 445,917 | - | - | Dec 31, 2023 |
| AMG FUNDS III | 0.16% | 26,052 | - | - | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.14% | 43,731 | -799 | -1.79% | Dec 31, 2023 |
| PRIMECAP Odyssey Funds | 0.13% | 1,094,200 | - | - | Jan 31, 2024 |
| REYNOLDS FUNDS INC | 0.12% | 1,400 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY VARIABLE PORTFOLIOS INC | 0.12% | 289,612 | -31,526 | -9.82% | Dec 31, 2023 |
| Humankind Benefit Corp | 0.11% | 2,340 | 368 | 18.66% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.10% | 835,800 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.10% | 43,073 | 927 | 2.20% | Dec 31, 2023 |
| COLUMBIA ACORN TRUST | 0.09% | 318,538 | - | - | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS V | 0.09% | 5,340,622 | -21,694 | -0.40% | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.09% | 43,630 | -41,930 | -49.01% | Dec 31, 2023 |
| MFS SERIES TRUST I | 0.09% | 1,661,704 | 154,087 | 10.22% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.08% | 510,601 | 35,084 | 7.38% | Dec 31, 2023 |
| DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 0.07% | 77,300 | - | - | Feb 29, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.07% | 43,553 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.07% | 29,421 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.06% | 29,163,980 | 5,219,746 | 21.80% | Dec 31, 2023 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.06% | 2,087,401 | - | - | Dec 31, 2023 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.05% | 253,143 | - | - | Dec 29, 2023 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.05% | 191,827 | 91,049 | 90.35% | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.04% | 8,035 | - | - | Dec 29, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,366,934 | 311,134 | 15.13% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.04% | 8,241 | - | - | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.03% | 177,847 | -12,868 | -6.75% | Mar 31, 2020 |
| WILLIAM BLAIR FUNDS | 0.03% | 2,539,790 | 175,950 | 7.44% | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.03% | 295,300 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 63,016 | - | - | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.02% | 7,424,720 | -2,444,548 | -24.77% | Dec 31, 2023 |
| Calvert Responsible Index Series, Inc. | 0.02% | 38,263 | - | - | Dec 31, 2023 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.02% | 224,242 | -139,137 | -38.29% | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 71,082 | 1,147 | 1.64% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.02% | 666,750 | -466,910 | -41.19% | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.02% | 84,970 | -4,580 | -5.11% | Dec 31, 2023 |
| ETFis Series Trust I | 0.02% | 26,201 | 3,324 | 14.53% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.02% | 199,057 | 66,663 | 50.35% | Mar 31, 2024 |
| ALPS ETF Trust | 0.02% | 202,813 | - | - | Feb 29, 2024 |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0.02% | 86,053 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,364,200 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.01% | 7,622 | -620 | -7.52% | Apr 30, 2021 |
| MFS VARIABLE INSURANCE TRUST | 0.01% | 442,083 | 145,555 | 49.09% | Dec 31, 2023 |
| Bernstein Fund Inc | 0.01% | 144,966 | - | - | Dec 31, 2023 |
| AMG Funds IV | 0.01% | 38,728 | - | - | Jan 31, 2024 |
| NEXPOINT FUNDS I | 0.01% | 48,800 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.01% | 29,416 | 1,555 | 5.58% | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 79,924 | - | - | Aug 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 2,492,681 | 142,546 | 6.07% | Feb 29, 2024 |
| Guardian Variable Products Trust | 0.01% | 198,000 | - | - | Dec 31, 2023 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 1,348 | - | - | Dec 29, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.01% | 319,029 | 71,756 | 29.02% | Dec 31, 2023 |
| IndexIQ ETF Trust | 0.01% | 22,919 | - | - | Jan 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.01% | 5,409 | 1,170 | 27.60% | Sep 30, 2020 |
| DELAWARE VIP TRUST | 0.01% | 31,328 | - | - | Dec 29, 2023 |
| ProFunds | 0.01% | 88,668 | 41,695 | 88.76% | Jan 31, 2024 |
| HARBOR FUNDS | 0.01% | 197,537 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.01% | 9,130 | -661 | -6.75% | Dec 31, 2023 |
| SSGA FUNDS | 0.01% | 3,261 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.01% | 1,377,861 | 81,580 | 6.29% | Feb 29, 2024 |
| VANGUARD HORIZON FUNDS | 0.01% | 157,092 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.01% | 202,229 | 12,318 | 6.49% | Dec 31, 2023 |
| JPMORGAN TRUST II | 0.01% | 6,776,210 | - | - | Feb 29, 2024 |
| JPMORGAN INSURANCE TRUST | 0.01% | 84,220 | -3,480 | -3.97% | Mar 31, 2023 |
| VANGUARD EXPLORER FUND | 0.01% | 78,779 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 17,199 | 5,401 | 45.78% | Dec 31, 2023 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.01% | 4,457 | -61 | -1.35% | Sep 30, 2023 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.01% | 78,775 | 37,363 | 90.22% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 75,452 | -7 | -0.01% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 71,106 | -3,599 | -4.82% | Dec 31, 2023 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 12,653 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 20,586 | - | - | Dec 31, 2023 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.01% | 217,859 | 51,219 | 30.74% | Dec 31, 2023 |
| MML SERIES INVESTMENT FUND | 0.01% | 48,533 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 763,630 | 207,439 | 37.30% | Jan 31, 2024 |
| Securian Funds Trust | 0.00% | 48,099 | - | - | Dec 31, 2023 |
| VALIC Co II | 0.00% | 168,325 | 14,356 | 9.32% | Feb 28, 2021 |
| Segall Bryant & Hamill Trust | 0.00% | 87,062 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 307,019 | -17,372 | -5.36% | Feb 29, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 3,300 | - | - | Dec 31, 2023 |
| Ivy Variable Insurance Portfolios | 0.00% | 91,713 | 1,921 | 2.14% | Dec 29, 2023 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.00% | 917,452 | - | - | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 152,307 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 791,154 | 15,451 | 1.99% | Feb 29, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 7,094 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 55,847 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 13,913 | -578 | -3.99% | Dec 31, 2023 |
Amicus Therapeutics's largest mutual fund holder by % of total assets is "Fiera Capital Series Trust", owning 130.47K shares, compromising 6.55% of its total assets.
Amicus Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 257 | 7.98% |
| 31 Dec, 23 | 238 | -0.83% |
| 30 Sep, 23 | 240 | 8.11% |
| 30 Jun, 23 | 222 | -2.20% |
| 31 Mar, 23 | 227 | -4.22% |
| 31 Dec, 22 | 237 | 3.49% |
| 30 Sep, 22 | 229 | 5.05% |
| 30 Jun, 22 | 218 | -1.36% |
| 31 Mar, 22 | 221 | -3.07% |
| 31 Dec, 21 | 228 | -8.80% |
| 30 Sep, 21 | 250 | 2.88% |
| 30 Jun, 21 | 243 | -9.67% |
| 31 Mar, 21 | 269 | -11.22% |
| 31 Dec, 20 | 303 | 16.54% |
| 30 Sep, 20 | 260 | 10.64% |
| 30 Jun, 20 | 235 | 10.85% |
| 31 Mar, 20 | 212 | -7.02% |
| 31 Dec, 19 | 228 | 6.05% |
| 30 Sep, 19 | 215 | 0.47% |
| 30 Jun, 19 | 214 | -2.28% |
| 31 Mar, 19 | 219 | 10.61% |
| 31 Dec, 18 | 198 | -8.33% |
| 30 Sep, 18 | 216 | -2.26% |
| 30 Jun, 18 | 221 | -3.07% |
| 31 Mar, 18 | 228 | 8.06% |
| 31 Dec, 17 | 211 | -4.09% |
| 30 Sep, 17 | 220 | 34.97% |
| 30 Jun, 17 | 163 | 6.54% |
| 31 Mar, 17 | 153 | -0.65% |
| 31 Dec, 16 | 154 | 2.67% |
| 30 Sep, 16 | 150 | 7.91% |
| 30 Jun, 16 | 139 | -6.08% |
| 31 Mar, 16 | 148 | -1.99% |
| 31 Dec, 15 | 151 | -4.43% |
| 30 Sep, 15 | 158 | 6.04% |
| 30 Jun, 15 | 149 | 11.19% |
| 31 Mar, 15 | 134 | 17.54% |
| 31 Dec, 14 | 114 | 11.76% |
| 30 Sep, 14 | 102 | 64.52% |
| 30 Jun, 14 | 62 | -8.82% |
| 31 Mar, 14 | 68 | - |
| 31 Dec, 13 | 68 | -6.85% |
| 30 Sep, 13 | 73 | 5.80% |
| 30 Jun, 13 | 69 | 97.14% |
| 31 Mar, 13 | 35 | 9.38% |
| 31 Dec, 12 | 32 | 6.67% |
| 30 Sep, 12 | 30 | -6.25% |
| 30 Jun, 12 | 32 | 33.33% |
| 31 Mar, 12 | 24 | 14.29% |
| 31 Dec, 11 | 21 | 5.00% |
| 30 Sep, 11 | 20 | -4.76% |
| 30 Jun, 11 | 21 | 61.54% |
| 31 Mar, 11 | 13 | 44.44% |
| 31 Dec, 10 | 9 | - |
| 30 Sep, 10 | 9 | -35.71% |
| 30 Jun, 10 | 14 | -22.22% |
| 31 Mar, 10 | 18 | - |
| 31 Dec, 09 | 18 | 28.57% |
| 30 Sep, 09 | 14 | -12.50% |
| 30 Jun, 09 | 16 | 45.45% |
| 31 Mar, 09 | 11 | -21.43% |
| 31 Dec, 08 | 14 | -6.67% |
| 30 Sep, 08 | 15 | 66.67% |
| 30 Jun, 08 | 9 | -25.00% |
| 31 Mar, 08 | 12 | - |
| 31 Dec, 07 | 12 | 20.00% |
| 30 Sep, 07 | 10 | 11.11% |
| 30 Jun, 07 | 9 | - |
As of 31 Mar 24, 257 institutions are holding Amicus Therapeutics's shares, representing an increase of 7.98% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 317,126,407 | -0.42% |
| 31 Dec, 23 | 318,467,004 | 7.53% |
| 30 Sep, 23 | 296,155,203 | -2.56% |
| 30 Jun, 23 | 303,931,015 | 2.41% |
| 31 Mar, 23 | 296,782,127 | 1.61% |
| 31 Dec, 22 | 292,069,049 | 0.06% |
| 30 Sep, 22 | 291,891,550 | -4.30% |
| 30 Jun, 22 | 305,009,102 | 0.63% |
| 31 Mar, 22 | 303,097,511 | 0.70% |
| 31 Dec, 21 | 300,996,328 | 2.72% |
| 30 Sep, 21 | 293,022,876 | 6.00% |
| 30 Jun, 21 | 276,435,337 | 0.20% |
| 31 Mar, 21 | 275,895,602 | -1.12% |
| 31 Dec, 20 | 279,014,168 | 0.50% |
| 30 Sep, 20 | 277,636,849 | -1.29% |
| 30 Jun, 20 | 281,270,650 | -0.66% |
| 31 Mar, 20 | 283,150,298 | 3.10% |
| 31 Dec, 19 | 274,634,239 | 0.56% |
| 30 Sep, 19 | 273,102,350 | 1.78% |
| 30 Jun, 19 | 268,336,055 | 7.25% |
| 31 Mar, 19 | 250,195,722 | 8.46% |
| 31 Dec, 18 | 230,680,669 | 1.06% |
| 30 Sep, 18 | 228,260,206 | 1.15% |
| 30 Jun, 18 | 225,670,958 | 0.90% |
| 31 Mar, 18 | 223,660,576 | 9.22% |
| 31 Dec, 17 | 204,777,203 | 3.62% |
| 30 Sep, 17 | 197,629,573 | 13.68% |
| 30 Jun, 17 | 173,851,221 | 2.99% |
| 31 Mar, 17 | 168,807,845 | 7.65% |
| 31 Dec, 16 | 156,818,587 | 5.74% |
| 30 Sep, 16 | 148,308,742 | 4.70% |
| 30 Jun, 16 | 141,647,004 | 1.39% |
| 31 Mar, 16 | 139,702,453 | 0.78% |
| 31 Dec, 15 | 138,617,257 | 2.95% |
| 30 Sep, 15 | 134,644,795 | 18.41% |
| 30 Jun, 15 | 113,711,317 | 39.04% |
| 31 Mar, 15 | 81,785,938 | 2.67% |
| 31 Dec, 14 | 79,655,301 | 69.44% |
| 30 Sep, 14 | 47,011,688 | 16.27% |
| 30 Jun, 14 | 40,432,963 | 18.64% |
| 31 Mar, 14 | 34,080,552 | -0.46% |
| 31 Dec, 13 | 34,237,487 | 15.16% |
| 30 Sep, 13 | 29,729,950 | 0.33% |
| 30 Jun, 13 | 29,633,434 | 180.50% |
| 31 Mar, 13 | 10,564,675 | 21.78% |
| 31 Dec, 12 | 8,675,158 | 20.15% |
| 30 Sep, 12 | 7,220,105 | -16.20% |
| 30 Jun, 12 | 8,615,961 | 9.43% |
| 31 Mar, 12 | 7,873,322 | 102.80% |
| 31 Dec, 11 | 3,882,251 | 29.06% |
| 30 Sep, 11 | 3,008,207 | -21.99% |
| 30 Jun, 11 | 3,856,081 | 29.46% |
| 31 Mar, 11 | 2,978,499 | 99.72% |
| 31 Dec, 10 | 1,491,325 | -22.46% |
| 30 Sep, 10 | 1,923,239 | -54.41% |
| 30 Jun, 10 | 4,218,909 | -11.51% |
| 31 Mar, 10 | 4,767,717 | 144.29% |
| 31 Dec, 09 | 1,951,691 | 133.66% |
| 30 Sep, 09 | 835,281 | -57.66% |
| 30 Jun, 09 | 1,972,739 | 3.19% |
| 31 Mar, 09 | 1,911,740 | -67.19% |
| 31 Dec, 08 | 5,826,729 | 19.08% |
| 30 Sep, 08 | 4,893,144 | 187.70% |
| 30 Jun, 08 | 1,700,792 | -54.76% |
| 31 Mar, 08 | 3,759,652 | 59.57% |
| 31 Dec, 07 | 2,356,143 | 36.86% |
| 30 Sep, 07 | 1,721,567 | 43.87% |
| 30 Jun, 07 | 1,196,619 | - |
Amicus Therapeutics (FOLD) has 317.13M shares outstanding as of 31 Mar 24, down -0.42% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 107.44% | 0.93% |
| 31 Dec, 23 | 107.68% | 1.05% |
| 30 Sep, 23 | 101.15% | 0.93% |
| 30 Jun, 23 | 104.32% | 1.01% |
| 31 Mar, 23 | 101.87% | 1.00% |
| 31 Dec, 22 | 101.04% | 0.99% |
| 30 Sep, 22 | 100.92% | 0.92% |
| 30 Jun, 22 | 104.47% | 0.95% |
| 31 Mar, 22 | 105.07% | 0.83% |
| 31 Dec, 21 | 112.54% | 0.94% |
| 30 Sep, 21 | 109.56% | 1.02% |
| 30 Jun, 21 | 103.77% | 0.95% |
| 31 Mar, 21 | 104.36% | 0.90% |
| 31 Dec, 20 | 107.78% | 0.94% |
| 30 Sep, 20 | 107.13% | 0.90% |
| 30 Jun, 20 | 109.03% | 0.90% |
| 31 Mar, 20 | 110.19% | 0.96% |
| 31 Dec, 19 | 106.87% | 0.93% |
| 30 Sep, 19 | 107.24% | 0.84% |
| 30 Jun, 19 | 112.70% | 0.82% |
| 31 Mar, 19 | 117.18% | 0.76% |
| 31 Dec, 18 | 124.16% | 0.85% |
| 30 Sep, 18 | 120.67% | 0.84% |
| 30 Jun, 18 | 119.64% | 0.74% |
| 31 Mar, 18 | 127.10% | 0.71% |
| 31 Dec, 17 | 133.53% | 0.88% |
| 30 Sep, 17 | 122.91% | 0.83% |
| 30 Jun, 17 | 121.57% | 0.87% |
| 31 Mar, 17 | 118.24% | 0.87% |
| 31 Dec, 16 | 116.68% | 1.05% |
| 30 Sep, 16 | 105.44% | 0.88% |
| 30 Jun, 16 | 109.70% | 0.88% |
| 31 Mar, 16 | 111.60% | 0.91% |
| 31 Dec, 15 | 110.74% | 0.86% |
| 30 Sep, 15 | 113.41% | 0.88% |
| 30 Jun, 15 | 113.72% | 1.56% |
| 31 Mar, 15 | 85.42% | 1.02% |
| 31 Dec, 14 | 91.61% | 2.58% |
| 30 Sep, 14 | 59.59% | 1.65% |
| 30 Jun, 14 | 60.16% | 2.14% |
| 31 Mar, 14 | 52.96% | 1.87% |
| 31 Dec, 13 | 53.20% | 1.48% |
| 30 Sep, 13 | 59.91% | 1.68% |
| 30 Jun, 13 | 59.72% | 13.17% |
| 31 Mar, 13 | 21.29% | 5.87% |
| 31 Dec, 12 | 19.04% | 8.60% |
| 30 Sep, 12 | 14.88% | 4.40% |
| 30 Jun, 12 | 18.38% | 4.26% |
| 31 Mar, 12 | 20.78% | 16.48% |
| 31 Dec, 11 | 11.23% | 15.19% |
| 30 Sep, 11 | 8.60% | 6.90% |
| 30 Jun, 11 | 11.17% | 14.98% |
| 31 Mar, 11 | 8.63% | 29.86% |
| 31 Dec, 10 | 5.38% | 11.09% |
| 30 Sep, 10 | 6.96% | 2.98% |
| 30 Jun, 10 | 15.27% | 3.96% |
| 31 Mar, 10 | 19.63% | 26.38% |
| 31 Dec, 09 | 8.63% | 63.27% |
| 30 Sep, 09 | 3.69% | 4.85% |
| 30 Jun, 09 | 8.72% | 12.20% |
| 31 Mar, 09 | 8.45% | 1.26% |
| 31 Dec, 08 | 25.90% | 5.49% |
| 30 Sep, 08 | 21.73% | 37.92% |
| 30 Jun, 08 | 7.57% | 2.69% |
| 31 Mar, 08 | 16.77% | 5.29% |
| 31 Dec, 07 | 17.80% | 10.52% |
| 30 Sep, 07 | 13.01% | 4.56% |
| 30 Jun, 07 | 16.89% | - |
As of 31 Mar 24, Amicus Therapeutics is held by 107.44% institutional shareholders, representing a 0.93% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 132 | - |
| 31 Dec, 23 | 132 | 2.33% |
| 30 Sep, 23 | 129 | 19.44% |
| 30 Jun, 23 | 108 | -12.90% |
| 31 Mar, 23 | 124 | -7.46% |
| 31 Dec, 22 | 134 | 27.62% |
| 30 Sep, 22 | 105 | 9.38% |
| 30 Jun, 22 | 96 | 6.67% |
| 31 Mar, 22 | 90 | -5.26% |
| 31 Dec, 21 | 95 | -17.39% |
| 30 Sep, 21 | 115 | 1.77% |
| 30 Jun, 21 | 113 | -19.86% |
| 31 Mar, 21 | 141 | - |
| 31 Dec, 20 | 141 | 22.61% |
| 30 Sep, 20 | 115 | -1.71% |
| 30 Jun, 20 | 117 | 21.88% |
| 31 Mar, 20 | 96 | -29.41% |
| 31 Dec, 19 | 136 | 11.48% |
| 30 Sep, 19 | 122 | -8.96% |
| 30 Jun, 19 | 134 | 15.52% |
| 31 Mar, 19 | 116 | 30.34% |
| 31 Dec, 18 | 89 | -18.35% |
| 30 Sep, 18 | 109 | 6.86% |
| 30 Jun, 18 | 102 | -18.40% |
| 31 Mar, 18 | 125 | 20.19% |
| 31 Dec, 17 | 104 | -21.80% |
| 30 Sep, 17 | 133 | 79.73% |
| 30 Jun, 17 | 74 | -9.76% |
| 31 Mar, 17 | 82 | - |
| 31 Dec, 16 | 82 | 6.49% |
| 30 Sep, 16 | 77 | -7.23% |
| 30 Jun, 16 | 83 | 7.79% |
| 31 Mar, 16 | 77 | -16.30% |
| 31 Dec, 15 | 92 | 3.37% |
| 30 Sep, 15 | 89 | -7.29% |
| 30 Jun, 15 | 96 | 24.68% |
| 31 Mar, 15 | 77 | -3.75% |
| 31 Dec, 14 | 80 | 19.40% |
| 30 Sep, 14 | 67 | 109.38% |
| 30 Jun, 14 | 32 | 28.00% |
| 31 Mar, 14 | 25 | -24.24% |
| 31 Dec, 13 | 33 | -2.94% |
| 30 Sep, 13 | 34 | -38.18% |
| 30 Jun, 13 | 55 | 139.13% |
| 31 Mar, 13 | 23 | 43.75% |
| 31 Dec, 12 | 16 | - |
| 30 Sep, 12 | 16 | -15.79% |
| 30 Jun, 12 | 19 | 11.76% |
| 31 Mar, 12 | 17 | 112.50% |
| 31 Dec, 11 | 8 | -27.27% |
| 30 Sep, 11 | 11 | -31.25% |
| 30 Jun, 11 | 16 | 100.00% |
| 31 Mar, 11 | 8 | 100.00% |
| 31 Dec, 10 | 4 | -33.33% |
| 30 Sep, 10 | 6 | 20.00% |
| 30 Jun, 10 | 5 | -50.00% |
| 31 Mar, 10 | 10 | 11.11% |
| 31 Dec, 09 | 9 | 80.00% |
| 30 Sep, 09 | 5 | -58.33% |
| 30 Jun, 09 | 12 | 200.00% |
| 31 Mar, 09 | 4 | -20.00% |
| 31 Dec, 08 | 5 | -50.00% |
| 30 Sep, 08 | 10 | 150.00% |
| 30 Jun, 08 | 4 | -42.86% |
| 31 Mar, 08 | 7 | -22.22% |
| 31 Dec, 07 | 9 | 50.00% |
| 30 Sep, 07 | 6 | -33.33% |
| 30 Jun, 07 | 9 | - |
132 institutional shareholders have increased their position in FOLD stock as of 31 Mar 24 compared to 132 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 77 | 22.22% |
| 31 Dec, 23 | 63 | 1.61% |
| 30 Sep, 23 | 62 | -15.07% |
| 30 Jun, 23 | 73 | 25.86% |
| 31 Mar, 23 | 58 | -6.45% |
| 31 Dec, 22 | 62 | -17.33% |
| 30 Sep, 22 | 75 | - |
| 30 Jun, 22 | 75 | -10.71% |
| 31 Mar, 22 | 84 | - |
| 31 Dec, 21 | 84 | 7.69% |
| 30 Sep, 21 | 78 | 2.63% |
| 30 Jun, 21 | 76 | -3.80% |
| 31 Mar, 21 | 79 | -17.71% |
| 31 Dec, 20 | 96 | 3.23% |
| 30 Sep, 20 | 93 | 29.17% |
| 30 Jun, 20 | 72 | - |
| 31 Mar, 20 | 72 | 35.85% |
| 31 Dec, 19 | 53 | - |
| 30 Sep, 19 | 53 | 51.43% |
| 30 Jun, 19 | 35 | -36.36% |
| 31 Mar, 19 | 55 | -14.06% |
| 31 Dec, 18 | 64 | 8.47% |
| 30 Sep, 18 | 59 | -13.24% |
| 30 Jun, 18 | 68 | 21.43% |
| 31 Mar, 18 | 56 | 1.82% |
| 31 Dec, 17 | 55 | 44.74% |
| 30 Sep, 17 | 38 | -17.39% |
| 30 Jun, 17 | 46 | 24.32% |
| 31 Mar, 17 | 37 | 5.71% |
| 31 Dec, 16 | 35 | -2.78% |
| 30 Sep, 16 | 36 | 28.57% |
| 30 Jun, 16 | 28 | -24.32% |
| 31 Mar, 16 | 37 | - |
| 31 Dec, 15 | 37 | -13.95% |
| 30 Sep, 15 | 43 | 22.86% |
| 30 Jun, 15 | 35 | - |
| 31 Mar, 15 | 35 | 105.88% |
| 31 Dec, 14 | 17 | 6.25% |
| 30 Sep, 14 | 16 | - |
| 30 Jun, 14 | 16 | -38.46% |
| 31 Mar, 14 | 26 | 36.84% |
| 31 Dec, 13 | 19 | -13.64% |
| 30 Sep, 13 | 22 | 266.67% |
| 30 Jun, 13 | 6 | 20.00% |
| 31 Mar, 13 | 5 | -37.50% |
| 31 Dec, 12 | 8 | 14.29% |
| 30 Sep, 12 | 7 | -12.50% |
| 30 Jun, 12 | 8 | 166.67% |
| 31 Mar, 12 | 3 | -62.50% |
| 31 Dec, 11 | 8 | 100.00% |
| 30 Sep, 11 | 4 | 33.33% |
| 30 Jun, 11 | 3 | -25.00% |
| 31 Mar, 11 | 4 | 33.33% |
| 31 Dec, 10 | 3 | 50.00% |
| 30 Sep, 10 | 2 | -50.00% |
| 30 Jun, 10 | 4 | 100.00% |
| 31 Mar, 10 | 2 | -60.00% |
| 31 Dec, 09 | 5 | 25.00% |
| 30 Sep, 09 | 4 | - |
| 30 Jun, 09 | 4 | 33.33% |
| 31 Mar, 09 | 3 | -40.00% |
| 31 Dec, 08 | 5 | 25.00% |
| 30 Sep, 08 | 4 | 33.33% |
| 30 Jun, 08 | 3 | -25.00% |
| 31 Mar, 08 | 4 | 100.00% |
| 31 Dec, 07 | 2 | -33.33% |
| 30 Sep, 07 | 3 | - |
| 30 Jun, 07 | - | - |
77 institutional shareholders have reduced their position in FOLD stock as of 31 Mar 24 compared to 63 in the previous quarter (a 22.22% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 257 | 7.98% | 317,126,407 | -0.42% | 107.44% | 0.93% | 132 | - | 77 | 22.22% |
| 31 Dec, 23 | 238 | -0.83% | 318,467,004 | 7.53% | 107.68% | 1.05% | 132 | 2.33% | 63 | 1.61% |
| 30 Sep, 23 | 240 | 8.11% | 296,155,203 | -2.56% | 101.15% | 0.93% | 129 | 19.44% | 62 | -15.07% |
| 30 Jun, 23 | 222 | -2.20% | 303,931,015 | 2.41% | 104.32% | 1.01% | 108 | -12.90% | 73 | 25.86% |
| 31 Mar, 23 | 227 | -4.22% | 296,782,127 | 1.61% | 101.87% | 1.00% | 124 | -7.46% | 58 | -6.45% |
| 31 Dec, 22 | 237 | 3.49% | 292,069,049 | 0.06% | 101.04% | 0.99% | 134 | 27.62% | 62 | -17.33% |
| 30 Sep, 22 | 229 | 5.05% | 291,891,550 | -4.30% | 100.92% | 0.92% | 105 | 9.38% | 75 | - |
| 30 Jun, 22 | 218 | -1.36% | 305,009,102 | 0.63% | 104.47% | 0.95% | 96 | 6.67% | 75 | -10.71% |
| 31 Mar, 22 | 221 | -3.07% | 303,097,511 | 0.70% | 105.07% | 0.83% | 90 | -5.26% | 84 | - |
| 31 Dec, 21 | 228 | -8.80% | 300,996,328 | 2.72% | 112.54% | 0.94% | 95 | -17.39% | 84 | 7.69% |
| 30 Sep, 21 | 250 | 2.88% | 293,022,876 | 6.00% | 109.56% | 1.02% | 115 | 1.77% | 78 | 2.63% |
| 30 Jun, 21 | 243 | -9.67% | 276,435,337 | 0.20% | 103.77% | 0.95% | 113 | -19.86% | 76 | -3.80% |
| 31 Mar, 21 | 269 | -11.22% | 275,895,602 | -1.12% | 104.36% | 0.90% | 141 | - | 79 | -17.71% |
| 31 Dec, 20 | 303 | 16.54% | 279,014,168 | 0.50% | 107.78% | 0.94% | 141 | 22.61% | 96 | 3.23% |
| 30 Sep, 20 | 260 | 10.64% | 277,636,849 | -1.29% | 107.13% | 0.90% | 115 | -1.71% | 93 | 29.17% |
| 30 Jun, 20 | 235 | 10.85% | 281,270,650 | -0.66% | 109.03% | 0.90% | 117 | 21.88% | 72 | - |
| 31 Mar, 20 | 212 | -7.02% | 283,150,298 | 3.10% | 110.19% | 0.96% | 96 | -29.41% | 72 | 35.85% |
| 31 Dec, 19 | 228 | 6.05% | 274,634,239 | 0.56% | 106.87% | 0.93% | 136 | 11.48% | 53 | - |
| 30 Sep, 19 | 215 | 0.47% | 273,102,350 | 1.78% | 107.24% | 0.84% | 122 | -8.96% | 53 | 51.43% |
| 30 Jun, 19 | 214 | -2.28% | 268,336,055 | 7.25% | 112.70% | 0.82% | 134 | 15.52% | 35 | -36.36% |
| 31 Mar, 19 | 219 | 10.61% | 250,195,722 | 8.46% | 117.18% | 0.76% | 116 | 30.34% | 55 | -14.06% |
| 31 Dec, 18 | 198 | -8.33% | 230,680,669 | 1.06% | 124.16% | 0.85% | 89 | -18.35% | 64 | 8.47% |
| 30 Sep, 18 | 216 | -2.26% | 228,260,206 | 1.15% | 120.67% | 0.84% | 109 | 6.86% | 59 | -13.24% |
| 30 Jun, 18 | 221 | -3.07% | 225,670,958 | 0.90% | 119.64% | 0.74% | 102 | -18.40% | 68 | 21.43% |
| 31 Mar, 18 | 228 | 8.06% | 223,660,576 | 9.22% | 127.10% | 0.71% | 125 | 20.19% | 56 | 1.82% |
| 31 Dec, 17 | 211 | -4.09% | 204,777,203 | 3.62% | 133.53% | 0.88% | 104 | -21.80% | 55 | 44.74% |
| 30 Sep, 17 | 220 | 34.97% | 197,629,573 | 13.68% | 122.91% | 0.83% | 133 | 79.73% | 38 | -17.39% |
| 30 Jun, 17 | 163 | 6.54% | 173,851,221 | 2.99% | 121.57% | 0.87% | 74 | -9.76% | 46 | 24.32% |
| 31 Mar, 17 | 153 | -0.65% | 168,807,845 | 7.65% | 118.24% | 0.87% | 82 | - | 37 | 5.71% |
| 31 Dec, 16 | 154 | 2.67% | 156,818,587 | 5.74% | 116.68% | 1.05% | 82 | 6.49% | 35 | -2.78% |
| 30 Sep, 16 | 150 | 7.91% | 148,308,742 | 4.70% | 105.44% | 0.88% | 77 | -7.23% | 36 | 28.57% |
| 30 Jun, 16 | 139 | -6.08% | 141,647,004 | 1.39% | 109.70% | 0.88% | 83 | 7.79% | 28 | -24.32% |
| 31 Mar, 16 | 148 | -1.99% | 139,702,453 | 0.78% | 111.60% | 0.91% | 77 | -16.30% | 37 | - |
| 31 Dec, 15 | 151 | -4.43% | 138,617,257 | 2.95% | 110.74% | 0.86% | 92 | 3.37% | 37 | -13.95% |
| 30 Sep, 15 | 158 | 6.04% | 134,644,795 | 18.41% | 113.41% | 0.88% | 89 | -7.29% | 43 | 22.86% |
| 30 Jun, 15 | 149 | 11.19% | 113,711,317 | 39.04% | 113.72% | 1.56% | 96 | 24.68% | 35 | - |
| 31 Mar, 15 | 134 | 17.54% | 81,785,938 | 2.67% | 85.42% | 1.02% | 77 | -3.75% | 35 | 105.88% |
| 31 Dec, 14 | 114 | 11.76% | 79,655,301 | 69.44% | 91.61% | 2.58% | 80 | 19.40% | 17 | 6.25% |
| 30 Sep, 14 | 102 | 64.52% | 47,011,688 | 16.27% | 59.59% | 1.65% | 67 | 109.38% | 16 | - |
| 30 Jun, 14 | 62 | -8.82% | 40,432,963 | 18.64% | 60.16% | 2.14% | 32 | 28.00% | 16 | -38.46% |
| 31 Mar, 14 | 68 | - | 34,080,552 | -0.46% | 52.96% | 1.87% | 25 | -24.24% | 26 | 36.84% |
| 31 Dec, 13 | 68 | -6.85% | 34,237,487 | 15.16% | 53.20% | 1.48% | 33 | -2.94% | 19 | -13.64% |
| 30 Sep, 13 | 73 | 5.80% | 29,729,950 | 0.33% | 59.91% | 1.68% | 34 | -38.18% | 22 | 266.67% |
| 30 Jun, 13 | 69 | 97.14% | 29,633,434 | 180.50% | 59.72% | 13.17% | 55 | 139.13% | 6 | 20.00% |
| 31 Mar, 13 | 35 | 9.38% | 10,564,675 | 21.78% | 21.29% | 5.87% | 23 | 43.75% | 5 | -37.50% |
| 31 Dec, 12 | 32 | 6.67% | 8,675,158 | 20.15% | 19.04% | 8.60% | 16 | - | 8 | 14.29% |
| 30 Sep, 12 | 30 | -6.25% | 7,220,105 | -16.20% | 14.88% | 4.40% | 16 | -15.79% | 7 | -12.50% |
| 30 Jun, 12 | 32 | 33.33% | 8,615,961 | 9.43% | 18.38% | 4.26% | 19 | 11.76% | 8 | 166.67% |
| 31 Mar, 12 | 24 | 14.29% | 7,873,322 | 102.80% | 20.78% | 16.48% | 17 | 112.50% | 3 | -62.50% |
| 31 Dec, 11 | 21 | 5.00% | 3,882,251 | 29.06% | 11.23% | 15.19% | 8 | -27.27% | 8 | 100.00% |
| 30 Sep, 11 | 20 | -4.76% | 3,008,207 | -21.99% | 8.60% | 6.90% | 11 | -31.25% | 4 | 33.33% |
| 30 Jun, 11 | 21 | 61.54% | 3,856,081 | 29.46% | 11.17% | 14.98% | 16 | 100.00% | 3 | -25.00% |
| 31 Mar, 11 | 13 | 44.44% | 2,978,499 | 99.72% | 8.63% | 29.86% | 8 | 100.00% | 4 | 33.33% |
| 31 Dec, 10 | 9 | - | 1,491,325 | -22.46% | 5.38% | 11.09% | 4 | -33.33% | 3 | 50.00% |
| 30 Sep, 10 | 9 | -35.71% | 1,923,239 | -54.41% | 6.96% | 2.98% | 6 | 20.00% | 2 | -50.00% |
| 30 Jun, 10 | 14 | -22.22% | 4,218,909 | -11.51% | 15.27% | 3.96% | 5 | -50.00% | 4 | 100.00% |
| 31 Mar, 10 | 18 | - | 4,767,717 | 144.29% | 19.63% | 26.38% | 10 | 11.11% | 2 | -60.00% |
| 31 Dec, 09 | 18 | 28.57% | 1,951,691 | 133.66% | 8.63% | 63.27% | 9 | 80.00% | 5 | 25.00% |
| 30 Sep, 09 | 14 | -12.50% | 835,281 | -57.66% | 3.69% | 4.85% | 5 | -58.33% | 4 | - |
| 30 Jun, 09 | 16 | 45.45% | 1,972,739 | 3.19% | 8.72% | 12.20% | 12 | 200.00% | 4 | 33.33% |
| 31 Mar, 09 | 11 | -21.43% | 1,911,740 | -67.19% | 8.45% | 1.26% | 4 | -20.00% | 3 | -40.00% |
| 31 Dec, 08 | 14 | -6.67% | 5,826,729 | 19.08% | 25.90% | 5.49% | 5 | -50.00% | 5 | 25.00% |
| 30 Sep, 08 | 15 | 66.67% | 4,893,144 | 187.70% | 21.73% | 37.92% | 10 | 150.00% | 4 | 33.33% |
| 30 Jun, 08 | 9 | -25.00% | 1,700,792 | -54.76% | 7.57% | 2.69% | 4 | -42.86% | 3 | -25.00% |
| 31 Mar, 08 | 12 | - | 3,759,652 | 59.57% | 16.77% | 5.29% | 7 | -22.22% | 4 | 100.00% |
| 31 Dec, 07 | 12 | 20.00% | 2,356,143 | 36.86% | 17.80% | 10.52% | 9 | 50.00% | 2 | -33.33% |
| 30 Sep, 07 | 10 | 11.11% | 1,721,567 | 43.87% | 13.01% | 4.56% | 6 | -33.33% | 3 | - |
| 30 Jun, 07 | 9 | - | 1,196,619 | - | 16.89% | - | 9 | - | - | - |
Amicus Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Amicus Therapeutics's stock was made by Campbell Bradley L on May 03 2024, selling 7,500 shares at $10.07 per share (valued at $75.52K).
Amicus Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | 5 | 40.00% |
| Q1 2024 | 31 | 65 | 47.69% |
| Q4 2023 | 10 | 23 | 43.48% |
| Q3 2023 | 9 | 30 | 30.00% |
| Q2 2023 | 21 | 15 | 140.00% |
| Q1 2023 | 25 | 50 | 50.00% |
| Q4 2022 | 3 | 15 | 20.00% |
| Q3 2022 | 3 | 19 | 15.79% |
| Q2 2022 | 15 | 15 | 100.00% |
| Q1 2022 | 20 | 26 | 76.92% |
| Q4 2021 | 9 | 23 | 39.13% |
| Q3 2021 | 12 | 19 | 63.16% |
| Q2 2021 | 45 | 33 | 136.36% |
| Q1 2021 | 29 | 39 | 74.36% |
| Q4 2020 | 25 | 43 | 58.14% |
| Q3 2020 | 36 | 55 | 65.45% |
| Q2 2020 | 38 | 41 | 92.68% |
| Q1 2020 | 40 | 67 | 59.70% |
| Q4 2019 | 7 | 18 | 38.89% |
| Q3 2019 | 4 | 6 | 66.67% |
2 total buy trades, and 5 total sell trades (buy/sell ratio of 0.40%) were made by Amicus Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 22 | - |
| Q4 2023 | - | 17 | - |
| Q3 2023 | - | 12 | - |
| Q2 2023 | - | 10 | - |
| Q1 2023 | - | 18 | - |
| Q4 2022 | - | 9 | - |
| Q3 2022 | - | 13 | - |
| Q2 2022 | - | 11 | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | 2 | 9 | 22.22% |
| Q3 2021 | 3 | 10 | 30.00% |
| Q2 2021 | 5 | 10 | 50.00% |
| Q1 2021 | 3 | 12 | 25.00% |
| Q4 2020 | 3 | 12 | 25.00% |
| Q3 2020 | 3 | 21 | 14.29% |
| Q2 2020 | 1 | 19 | 5.26% |
| Q1 2020 | - | 25 | - |
| Q4 2019 | - | 6 | - |
| Q3 2019 | 1 | 3 | 33.33% |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Amicus Therapeutics's stocks.
Amicus Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DNLI | Denali Therapeutics Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| DICE | DICE Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| BMRN | BioMarin Pharmaceutical Inc. |
| HRMY | Harmony Biosciences Holdings, Inc. |
| ARVN | Arvinas, Inc. |
| INBX | Inhibrx, Inc. |
| ARGX | argenx SE |
| DYN | Dyne Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| INCY | Incyte Corporation |
| LEGN | Legend Biotech Corporation |
| BPMC | Blueprint Medicines Corporation |
| CYTK | Cytokinetics, Incorporated |
| KURA | Kura Oncology, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| RARE | Ultragenyx Pharmaceutical Inc. |
| AGIO | Agios Pharmaceuticals, Inc. |
FOLD Ownership FAQ
Who Owns Amicus Therapeutics?
Amicus Therapeutics is owned by institutional shareholders (107.44%), insiders (0.75%), and public (-8.19%). The largest institutional shareholder of Amicus Therapeutics is VANGUARD GROUP INC (9.56% of total shares) and the top mutual fund owner is Fiera Capital Series Trust (6.55% of total shares).
Who are the major institutional shareholders of Amicus Therapeutics?
Amicus Therapeutics's major institutional shareholders are VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, AVORO CAPITAL ADVISORS LLC, BLACKROCK INC., and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 42.46% of the company's share outstanding.
How many Amicus Therapeutics shareholders are there?
As of Mar 2024, there are 257 institutional shareholders of Amicus Therapeutics.
What percentage of Amicus Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 28.2M shares of Amicus Therapeutics, representing 9.56% of the company's total shares outstanding, valued at $332.25M (as of Mar 2024).
What percentage of Amicus Therapeutics is owned by PERCEPTIVE ADVISORS LLC?
As of Mar 2024, PERCEPTIVE ADVISORS LLC holds 28.06M shares of Amicus Therapeutics (FOLD), compromising 9.51% of the company, valued at $330.52M.
What percentage of Amicus Therapeutics is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC is the third largest holder of Amicus Therapeutics. The company owns 27.4M of the company's shares outstanding (worth $322.77M).